IMAX Salute del bilancio
Criteri Salute finanziaria verificati 5/6
IMAX ha un patrimonio netto totale di $428.3M e un debito totale di $290.8M, che porta il suo rapporto debito/patrimonio netto a 67.9%. Le sue attività totali e le sue passività totali sono rispettivamente $893.2M e $464.8M. L'EBIT di IMAX è $87.3M rendendo il suo rapporto di copertura degli interessi 18.5. Ha liquidità e investimenti a breve termine pari a $146.0M.
Informazioni chiave
67.90%
Rapporto debito/patrimonio netto
US$290.83m
Debito
| Indice di copertura degli interessi | 18.5x |
| Contanti | US$146.00m |
| Patrimonio netto | US$428.34m |
| Totale passività | US$464.81m |
| Totale attività | US$893.15m |
Aggiornamenti recenti sulla salute finanziaria
Articolo di analisi • Mar 15
We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Articolo di analisi • Oct 31
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Jun 19
Is IMAX (NYSE:IMAX) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Recent updates
Aggiornamento della narrazione • May 02
IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power
The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
Aggiornamento della narrazione • Apr 18
IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside
The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.Aggiornamento della narrazione • Apr 04
IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk
Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.Aggiornamento della narrazione • Mar 21
IMAX: Record Box Office And Premium Format Position Will Support Future Upside
The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.Aggiornamento della narrazione • Mar 06
IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk
The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
Aggiornamento della narrazione • Feb 20
IMAX: Live Sports And Content Partnerships Will Support Future Upside
Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.Aggiornamento della narrazione • Feb 05
IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities
Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.Aggiornamento della narrazione • Jan 22
IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential
Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.Seeking Alpha • Jan 09
IMAX Corporation: Strong Network Effect And Visible Growth Ahead
Summary I rate IMAX Corp. a buy, citing strong network effects, visible near-term growth, and a resilient, diversified revenue profile. IMAX's network remains less than 40% penetrated, with over 470 confirmed system orders and a robust blockbuster and local-language content pipeline. The Netflix Narnia partnership signals a strategic shift, potentially expanding IMAX’s content supply beyond traditional studios to major streaming platforms. Consensus estimates appear overly cautious; applying an 11x EBITDA multiple implies ~30% upside from current market cap, with key risks in streaming adoption and China exposure. Read the full article on Seeking AlphaAggiornamento della narrazione • Jan 08
IMAX: Premium Screens And Local Language Hits Will Support Future Upside
Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.Aggiornamento della narrazione • Dec 21
IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance
Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.Aggiornamento della narrazione • Dec 07
IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance
We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.Aggiornamento della narrazione • Nov 22
IMAX: Future Box Office Releases And Network Expansion Will Shape Performance
IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.Aggiornamento della narrazione • Nov 01
IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance
The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.Aggiornamento della narrazione • Oct 18
North America And Japan Installations Will Strengthen Premium Entertainment
Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.Aggiornamento della narrazione • Oct 04
North America And Japan Installations Will Strengthen Premium Entertainment
IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.Articolo di analisi • Sep 09
Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Articolo di analisi • Aug 04
Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...Articolo di analisi • Jun 13
An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued
Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...Articolo di analisi • May 17
Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Articolo di analisi • May 02
IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear
Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...Articolo di analisi • Apr 19
Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...Articolo di analisi • Apr 04
Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Articolo di analisi • Mar 15
We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Seeking Alpha • Mar 09
IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema
Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking AlphaArticolo di analisi • Jan 08
Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...Seeking Alpha • Dec 24
IMAX Corporation: Overseas Growth Opportunities
Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking AlphaArticolo di analisi • Dec 10
IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Articolo di analisi • Nov 23
IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...Articolo di analisi • Nov 07
After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar
The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...Articolo di analisi • Oct 31
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Oct 13
If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Seeking Alpha • Oct 10
IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential
Summary IMAX Corporation has a long growth runway in international markets, as the foreign markets' IMAX theater network penetration rate is lower than that for the US. IMAX can achieve higher profit margins in the future with rising top line contribution from alternative content that boosts the company's overall capacity utilization rate. IMAX stock is trading at below 1 times PEG, which implies that it is undervalued relative to its financial improvement potential. Read the full article on Seeking AlphaArticolo di analisi • Sep 30
When Should You Buy IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it received a lot of attention from a substantial...
Nuova narrazione • Sep 24
Calculated Global Expansion And Innovative Content Slate Set To Propel Growth
IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.Articolo di analisi • Aug 23
Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Seeking Alpha • Jul 30
IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings
Summary IMAX Corporation provides technology to movie theaters bringing an immersive experience, in part protecting the company from the rise of digital streaming platforms. After consistent backlog declines, IMAX finally reported great new signings in Q2, providing a great midterm growth outlook with a great new blockbuster movie pipeline. While IMAX's midterm growth outlook is great, the stock already prices in good growth, mitigating a very significant investment opportunity from the upbeat outlook. Read the full article on Seeking AlphaArticolo di analisi • Jul 26
Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now
When you see that almost half of the companies in the Entertainment industry in the United States have price-to-sales...Articolo di analisi • Jun 19
Is IMAX (NYSE:IMAX) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • May 22
Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...Seeking Alpha • Apr 08
IMAX Corporation: Good Reasons To Be Bullish
Summary IMAX Corporation's short-to-medium term performance is expected to be good, as the company is grabbing a bigger slice of the global box office and gaining recognition from the film industry's players. For the long term, IMAX is actively diversifying into non-film content like events and documentaries to reduce its reliance on movies over time. I view IMAX stock as a good investment candidate, as there are multiple positive factors for the shares. Read the full article on Seeking AlphaArticolo di analisi • Mar 01
IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next
It's been a pretty great week for IMAX Corporation ( NYSE:IMAX ) shareholders, with its shares surging 13% to US$17.13...Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $461.0M ) di IMAX superano le sue passività a breve termine ( $100.8M ).
Passività a lungo termine: Le attività a breve termine di IMAX ( $461.0M ) superano le sue passività a lungo termine ( $364.0M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 33.8% ) di IMAX è considerato soddisfacente.
Riduzione del debito: Il rapporto debito/patrimonio netto di IMAX è aumentato da 62.8% a 67.9% negli ultimi 5 anni.
Copertura del debito: Il debito di IMAX è ben coperto dal flusso di cassa operativo ( 42.7% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di IMAX sono ben coperti dall'EBIT ( 18.5 x copertura).
Bilancio
Scoprire le aziende sane
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/22 18:55 |
| Prezzo dell'azione a fine giornata | 2026/05/22 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
IMAX Corporation è coperta da 20 analisti. 11 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Marla Backer | Ascendiant Capital Markets LLC |
| David McFadgen | ATB Cormark Historical (Cormark Securities) |
| Patrick Sholl | Barrington Research Associates, Inc. |